Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study

Archive ouverte

Ursenbach, Axel | Max, Vincent | Maurel, Marine | Bani-Sadr, Firouzé | Gagneux-Brunon, Amandine | Garraffo, Rodolphe | Ravaux, Isabelle | Robineau, Olivier | Makinson, Alain | Rey, David | Drobacheff-Thiébaut, C | Foltzer, A | Bouiller, K | Hustache-Mathieu, L | Chirouze, C | Lepiller, Q | Bozon, F | Babre, O | Brunel, A | Muret, P | Laurichesse, H | Lesens, O | Vidal, M | Mrozek, N | Aumeran, C | Baud, O | Corbin, V | Letertre-Gibert, P | Casanova, S | Prouteau, J | Jacomet, C | Lamaury, I | Fabre, I | Curlier, E | Ouissa, R | Herrmann-Storck, C | Tressieres, B | Bonijoly, T | Receveur, M | Boulard, F | Daniel, C | Clavel, C | Merrien, D | Perré, P | Guimard, T | Bollangier, O | Leautez, S | Morrier, M | Laine, L | Ader, F | Becker, A | Biron, F | Boibieux, A | Cotte, L | Ferry, T | Miailhes, P | Perpoint, T | Roux, Stéphane | Triffault-Fillit, C | Degroodt, S | Brochier, C | Valour, F | Chidiac, C | Ménard, A | Belkhir, A | Colson, P | Dhiver, C | Madrid, A | Martin-Degiovani, M | Meddeb, L | Mokhtari, M | Motte, A | Raoux, A | Tamalet, C | Toméi, C | Dupont, H Tissot | Brégigeon, S | Zaegel-Faucher, O | Obry-Roguet, V | Laroche, H | Orticoni, M | Soavi, M | de Lamarlière, P Geneau | Ressiot, E | Ducassou, M | Jaquet, I | Galie, S | Galinier, A | Martinet, P | Landon, M | Ritleng, A | Ivanova, A | Debreux, C | Lions, C | Poizot-Martin, I | Abel, S | Cabras, O | Cuzin, L | Guitteaud, K | Illiaquer, M | Pierre-François, S | Osei, L | Pasquier, J | Rome, K | Sidani, E | Turmel, J | Varache, C | Cabié, A | Atoui, N | Bistoquet, M | Delaporte, E | Le Moing, V | Meftah, N | de Boever, C Merle | Montes, B | Ferrer, a Montoya | Tuaillon, E | Reynes, J | André, M | Boyer, L | Bouillon, M | Delestan, M | Rabaud, C | May, T | Hoen, B | Allavena, C | Bernaud, C | Billaud, E | Biron, C | Bonnet, B | Bouchez, S | Boutoille, D | Brunet-Cartier, C | Deschanvres, C | Hall, N | Morineau, P | Reliquet, V | Sécher, S | Cavellec, M | Soria, A | Ferré, V | André-Garnier, E | Rodallec, A | Lefebvre, M | Grossi, O | Aubry, O | Raffi, F | Pugliese, P | Breaud, S | Ceppi, C | Chirio, D | Cua, E | Dellamonica, P | Demonchy, E | de Monte, A | Durant, J | Etienne, C | Ferrando, S | Michelangeli, C | Mondain, V | Naqvi, A | Oran, N | Perbost, I | Pillet, S | Pradier, C | Prouvost-Keller, B | Risso, K | Rio, V | Roger, P | Rosenthal, E | Sausse, S | Touitou, I | Wehrlen-Pugliese, S | Zouzou, G | Hocqueloux, L | Prazuck, T | Gubavu, C | Sève, A | Maka, A | Boulard, C | Thomas, G | Cheret, A | Goujard, C | Quertainmont, Y | Teicher, E | Lerolle, N | Deradji, O | Barrail-Tran, A | Landman, R | Joly, V | Ghosn, J | Rioux, C | Lariven, S | Gervais, A | Lescure, F | Matheron, S | Louni, F | Julia, Z | Mackoumbou-Nkouka, C | Le Gac, S | Charpentier, C | Descamps, D | Peytavin, G | Yazdanpanah, Y | Amazzough, K | Avettand-Fenoël, V | Benabdelmoumen, G | Bossi, P | Cessot, G | Charlier, C | Consigny, P | Danion, F | Dureault, A | Duvivier, C | Goesch, J | Guery, R | Henry, B | Jidar, K | Lanternier, F | Loubet, P | Lortholary, O | Louisin, C | Lourenco, J | Parize, P | Pilmis, B | Touam, F | Valantin, M | Tubiana, R | Agher, R | Seang, S | Schneider, L | Palich, R | Blanc, C | Katlama, C | Berger, J | N’guyen, Y | Lambert, D | Kmiec, I | Hentzien, M | Brunet, A | Brodard, V | Tattevin, P | Revest, M | Souala, F | Baldeyrou, M | Patrat-Delon, S | Chapplain, J | Benezit, F | Dupont, M | Poinot, M | Maillard, A | Pronier, C | Lemaitre, F | Guennoun, C | Poisson-Vanier, M | Jovelin, T | Sinteff, J | Arvieux, C | Botelho-Nevers, E | Frésard, A | Ronat, V | Lucht, F | Fischer, P | Partisani, M | Cheneau, C | Priester, M | Batard, M | Bernard-Henry, C | de Mautort, E | Fafi-Kremer, S | Alvarez, M | Biezunski, N | Debard, A | Delpierre, C | Lansalot, P | Lelièvre, L | Martin-Blondel, G | Piffaut, M | Porte, L | Saune, K | Delobel, Pierre | Ajana, F | Aïssi, E | Alcaraz, I | Baclet, V | Bocket, L | Boucher, A | Choisy, P | Huleux, T | Lafon-Desmurs, B | Meybeck, A | Pradier, M | Viget, N | Valette, M

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Background Integrase strand transfer inhibitors (INSTIs) are increasingly used in patients living with HIV due to their safety, effectiveness and high genetic barrier. However, an association with weight gain has recently been suggested and several cases of diabetes mellitus have been reported with raltegravir and dolutegravir. The long-time metabolic impact of these recent molecules remains unclear. Objectives To assess if an INSTI as a third agent is statistically associated with new-onset diabetes mellitus compared with an NNRTI or a PI. Patients and methods Patients undergoing first-line combined ART (cART) without diabetes at baseline were retrospectively included from the Dat’AIDS French cohort study (ClinicalTrials.gov NCT02898987). Incident diabetes mellitus was defined as a notification of new diabetes in the medical history, a glycated haemoglobin (HbA1c) level superior to 7.5% or the start of a diabetes therapy following the initiation of ART. Results From 2009 to 2017, 19 462 patients were included, among which 265 cases of diabetes mellitus occurred. Multivariate and survival analyses did not highlight an increase in new-onset diabetes in patients undergoing cART with an INSTI as a third agent compared with an NNRTI or a PI. BMI >30 kg/m2, age >37 years old (in survival analysis), black race or Hispanic ethnicity, arterial hypertension and AIDS were associated with a higher proportion of incident diabetes. Conclusions INSTIs were not statistically associated with new-onset diabetes. However, clinicians should remain aware of this possible metabolic comorbidity, particularly in patients with a high BMI and older patients.

Consulter en ligne

Suggestions

Du même auteur

Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018

Archive ouverte | Pradat, Pierre | CCSD

International audience. Abstract Background The arrival of highly effective, well-tolerated, direct-acting antiviral agents (DAA) led to a dramatic decrease in hepatitis C virus (HCV) prevalence. Human immunodeficie...

Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting

Archive ouverte | Deschanvres, Colin | CCSD

International audience. Background Maintenance ART with dolutegravir-based dual regimens have proved their efficacy among HIV-1-infected subjects in randomized trials. However, real-life data are scarce, with limite...

Reaching the Second and Third Joint United Nations Programme on Human Immunodeficiency Virus (HIV)/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary HIV Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort

Archive ouverte | Le Guillou, Adrien | CCSD

International audience. Background In late 2013, France was one of the first countries to recommend initiation of combination antiretroviral therapy (cART) irrespective of CD4 cell count. Methods To assess the impac...

Chargement des enrichissements...